A Phase I Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies

Trial Profile

A Phase I Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies

Discontinued
Phase of Trial: Phase I

Latest Information Update: 24 Jun 2015

At a glance

  • Drugs Carboplatin (Primary) ; Pazopanib (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Mar 2015 Planned End Date changed from 1 Aug 2017 to 1 Dec 2015 as reported by ClinicalTrials.gov.
    • 21 Mar 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to discontinued.
    • 14 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top